Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-07

Clinical Trial Update: Effect of Benzalkonium Chloride Containing Eye Drops on the Conjunctival Bacterial Flora of Dry Eye Patients [Phase 4]

View source ↗

Summary

Phase 4 trial examining how benzalkonium chloride-containing eye drops affect the conjunctival bacterial flora in patients with dry eye syndromes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Medical University of Vienna | Conditions: Dry Eye Syndromes | Phase 4 | Status: UNKNOWN